PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-β/δ and PPAR-γ

L Han, WJ Shen, S Bittner, FB Kraemer… - Future cardiology, 2017 - Taylor & Francis
The PPARs are a subfamily of three ligand-inducible transcription factors, which belong to
the superfamily of nuclear hormone receptors. In mammals, the PPAR subfamily consists of …

Interactions between inflammation and lipid metabolism: relevance for efficacy of anti-inflammatory drugs in the treatment of atherosclerosis

JA van Diepen, JFP Berbée, LM Havekes… - Atherosclerosis, 2013 - Elsevier
Dyslipidemia and inflammation are well known causal risk factors the development of
atherosclerosis. The interplay between lipid metabolism and inflammation at multiple levels …

PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α

L Han, WJ Shen, S Bittner, FB Kraemer… - Future cardiology, 2017 - Taylor & Francis
This article provides a comprehensive review about the molecular and metabolic actions of
PPAR-α. It describes its structural features, ligand specificity, gene transcription …

PPARs integrate the mammalian clock and energy metabolism

L Chen, G Yang - PPAR research, 2014 - Wiley Online Library
Peroxisome proliferator‐activated receptors (PPARs) are a group of nuclear receptors that
function as transcription factors regulating the expression of numerous target genes. PPARs …

[HTML][HTML] Nutrition, microRNAs, and human health

J Cui, B Zhou, SA Ross, J Zempleni - Advances in nutrition, 2017 - Elsevier
MicroRNAs (miRs) hybridize with complementary sequences in mRNA and silence genes by
destabilizing mRNA or preventing translation of mRNA. Over 60% of human protein-coding …

PPARα: An emerging target of metabolic syndrome, neurodegenerative and cardiovascular diseases

Y Lin, Y Wang, P Li - Frontiers in Endocrinology, 2022 - frontiersin.org
Peroxisome proliferator-activated receptor α (PPARα) is a ligand-activated transcription
factor that is involved in lipid metabolism of various tissues. Different metabolites of fatty …

Angiotensin II AT1 receptor blockers as treatments for inflammatory brain disorders

JM Saavedra - Clinical science, 2012 - portlandpress.com
The effects of brain AngII (angiotensin II) depend on AT1 receptor (AngII type 1 receptor)
stimulation and include regulation of cerebrovascular flow, autonomic and hormonal …

Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-β and NF-κB

S Purkayastha, G Zhang, D Cai - Nature medicine, 2011 - nature.com
Obesity-related hypertension has become an epidemic health problem and a major risk
factor for the development of cardiovascular disease (CVD). Recent research on the …

Anti-angiogenic properties of ginsenoside Rg3

M Nakhjavani, E Smith, AR Townsend, TJ Price… - Molecules, 2020 - mdpi.com
Ginsenoside Rg3 (Rg3) is a member of the ginsenoside family of chemicals extracted from
Panax ginseng. Like other ginsenosides, Rg3 has two epimers: 20 (S)-ginsenoside Rg3 …

Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease

S Azhar - Future cardiology, 2010 - Taylor & Francis
Metabolic syndrome (MetS) is a constellation of risk factors including insulin resistance,
central obesity, dyslipidemia and hypertension that markedly increase the risk of Type 2 …